or
Bookmark and Share
Antifungal 1,3-bis-triazolyl-2-propanol derivative
   
Document Number
US Patent 4404216
Issued Date
September 13, 1983
Link
Inventors
Map
Abstract
2-(2,4-Difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol and its pharmaceutically acceptable acid addition salts are disclosed. This particular bis-triazole derivative and its aforesaid salts are useful for treating fungal infections in animals, including humans. Methods for preparing these compounds from known starting materials are provided.
Drawing
Antifungal 1,3-bis-triazolyl-2-propanol derivative - US Patent 4404216 Drawing
Drawing from US Patent 4404216
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
3
Comments:
no comments yet
Owner
Pfizer Inc. (New York, NY)
Published
September 13, 1983
Application Number
06/383,866
Filed
June 1, 1982
US Classification
514/383   260/665G 260/665R 548/266.6 549/563 568/335 568/812
Int'l Classification
C07C   33/00   (20060101)   C07C   33/46   (20060101)   C07C   29/00   (20060101)   C07C   29/40   (20060101)   C07C   45/00   (20060101)   C07C   45/46   (20060101)   C07D   521/00   (20060101)  
Priority Data
Jun 06, 1981 [GB] 8117379 Oct 17, 1981 [GB] 8131370 Mar 04, 1982 [GB] 8206329
USPTO Field of Search
548/262   424/269  
Related Patents
5710280 - Preparation of fluconazole and pharmaceutically acceptable salts thereof - Owned by Development Center for Biotechnology (TW)

A process for preparing fluconazole, including the steps of (1) acylating 1,3-difluorobenzene (DFB) to obtain 2-chloro-2',4'-difluoroacetophenone (CAP); (2) alkylating 4-amino-4H-1,2,4-triazole (4-AT) with CAP to obtain 2-(1H-1,2,4-triazol-1-yl)-2',4'-difluoroacetophenone (TAAP) salt; (3) deaminating TAAP salt to obtain TAAP; and (4) reacting TAAP with 1,2,4-triazole to obtain fluconazole.

5750719 - Commercial process for the manufacture of fluconazole and intermediates useful in the manufacture thereof - Owned by Brantford Chemicals Inc. (Brantford,CA)

A process for making Fluconazole is provided comprising carrying out the following scheme of reaction: ##STR1##

5484936 - Processes for the preparation of 1,3-bis(1,2,4-triazol-1-yl)-propan-2-ol derivatives - Owned by Teva Pharmaceutical Industries Ltd. (Jerusalem,IL)

The invention provides a regiospecific process for the preparation of 1,3-bis(1,2,4-triazol-1-yl)-propan-2-ol derivatives comprising reacting an oxirane acid salt or an oxirane, under acidic conditions, with 4H-4-amino-1,2,4-triazole. The process is particularly useful for preparing fluconazole which is useful in the treatment of fungal infections in animals and humans.

4554286 - Antifungal 1-triazolyl-2-aryl-3-(5-trifluoromethylimidazol-1-yl)propan-2-ol derivatives - Owned by Pfizer Inc. (New York, NY)

1-Triazolyl-2-aryl-3-(5-trifluoromethylimidazol-1-yl)propan-2-ol derivatives useful in the treatment of fungal infections in humans, animals and plants, and their preparation.

4466974 - Bistriazole antifungal agents - Owned by Pfizer Inc. (New York, NY)

Compounds of the formula ##STR1## wherein X is an amine function and R is substituted phenyl and their pharmaceutically acceptable salts are useful antifungal agents in animals, including man.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us